Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-07-013816
Filing Date
2007-02-27
Accepted
2007-02-27 17:12:45
Documents
2
Period of Report
2007-02-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5688
2 POA DOCUMENT poa.txt EX-24.4_175218 3559
  Complete submission text file 0001209191-07-013816.txt   11123
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 261 BALLARDVALE STREET WILMINGTON MA 01867 9786586000
CHARLES RIVER LABORATORIES INTERNATIONAL INC (Issuer) CIK: 0001100682 (see all company filings)

EIN.: 061397316
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 251 BALLARDVALE STREET WILMINGTON MA 01887
Business Address 978-658-6000
Ventresca Nicholas (Reporting) CIK: 0001358345 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15943 | Film No.: 07654181